Related Experiment Videos
IgE-producing low-grade non-Hodgkin lymphoma
C Sundström1, K Nilsson, G Brenning
1Department of Pathology, University Hospital, University of Uppsala, Sweden.
European Journal of Haematology
|October 1, 1988
Summary
This case study describes a rare instance of IgE-producing non-Hodgkin lymphoma (NHL). Despite initial treatment, the patient succumbed to the progressive lymphoma, highlighting the aggressive nature of this specific B-cell malignancy.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Non-Hodgkin lymphoma (NHL) is a diverse group of lymphoid malignancies.
- Elevated immunoglobulin E (IgE) levels are uncommon in NHL.
- This report details a unique case involving IgE production.
Observation:
- A patient presented with a 6-year history of rising IgE levels preceding a low-grade NHL diagnosis.
- The lymphoma infiltrated lymph nodes, skin, bone marrow, and lungs.
- Tumor morphology varied, resembling lymphoplasmacytic immunocytoma and centrocytic lymphoma.
Findings:
- Immunophenotype studies confirmed intracytoplasmic IgE lambda within tumor cells.
- Tumor cells exhibited a B-cell surface phenotype (BB-1 positive, OKT10 positive, PCA weakly positive, surface IgE lambda positive).
Implications:
- This case underscores the importance of considering IgE-producing NHL in patients with unexplained hyper-IgE.
- Understanding the immunophenotypic characteristics of such rare lymphomas is crucial for diagnosis and potential therapeutic strategies.
- Further research into the pathogenesis of IgE-producing B-cell lymphomas may reveal novel treatment targets.